Introduction
============

Early detection of renal dysfunction in intensive care unit (ICU) patients is important. Indeed, an increase of the glomerular filtration rate (GFR) was demonstrated in some ICU patients populations by using urinary creatinine clearance (CL~CR~) as a surrogate marker, and many of the drugs used in ICU patients need dose adjustment as a function of GFR \[[@B1]\]. Despite a normal serum creatinine measurement, a substantial number of burn patients demonstrated an increase in GFR with the need for increasing doses of renal elimination drugs to maintain therapeutic concentrations \[[@B1],[@B2]\]. A study of our group showed that 42% of burn patients had a creatinine clearance greater than 120 mL minute^-1^1.73 m^2^\[[@B1]\]. Also, several studies performed in a general population of ICU patients suggested a poor correlation between serum creatinine concentration and GFR in polytrauma patients (PT) \[[@B3]-[@B5]\]. To the best of our knowledge, no study has specifically explored this population of PT patients.

The aim of this study, performed in a population of ICU patients with normal serum creatinine, was to estimate GFR, evaluated by measured CL~CR~, in a population of PT patients through a comparison with a population of non-trauma patients (NPT).

Materials and methods
=====================

Patients
--------

This observational study was conducted in the ICU of Toulouse University hospital during a five-year period (November 2002 to December 2007). The study was performed according to the Declaration of Helsinki. No change in our current clinical practice (measured creatinine clearance monitoring, at least once a week, is a part of the routine medical care of the patients) and no randomization was performed. As it was an observational retrospective study, in accordance with French law, neither approval of the ethics committee nor informed consent was required.

Ten days, on average, after admission in ICU, consecutive critically ill patients meeting the inclusion criteria were included. Inclusion criteria were: patients older than 18 years, with an arterial catheter, a urinary bladder catheter, a diuresis over 500 mL d^-1^. All patients had a tracheal tube and were mechanically ventilated. Patients were hemodynamically stable presenting with a stable serum creatinine in a normal range (40 to 125 μmol L^-1^).

Patients were excluded from the study: if they were hemodynamically unstable or if they needed a high dose of catecholamine (norepinephrine \> 1 mg h^-1^); if they were recovering from acute kidney injury (AKI) or developing AKI; if they received histamine-2-receptor antagonist due to its interference with tubular creatinine secretion \[[@B6]\]; and if they had a medical history of diabetes, of chronic hepatic disease, cirrhosis or ongoing liver dysfunction with hepatitis \[[@B7],[@B8]\]. Patients treated with diuretics were also excluded.

Baseline characteristics of patients were recorded at enrolment in the study and the SAPS II was obtained at ICU admission. PT patients had an ISS (Injury Severity Score) \> 16. SOFA (Sequential Organ Failure Assessment) score was obtained on the day the urine 24-hour measure was sampled \[[@B9]-[@B11]\].

Urine was sampled over 24 hours to measure urinary creatinine concentration. Serum creatinine was also measured during the urine collection period.

The normal limits of CL~CR~were estimated between 60 and 120 mL minute^-1^1.73 m^-2^\[[@B9],[@B12]\].

Serum creatinine measurement and calibration
--------------------------------------------

Creatinine measurements were performed in the same laboratory of the University Hospital of Toulouse. Blood samples were obtained simultaneously with the CL~CR~measurement. A modified kinetic Jaffe colorimetric method was used with a COBAS MIRA (ABX Diagnostics, Montpellier, France) analyzer. A two-point calibration was applied in each assay.

Before measurement, ultrafiltration of plasma through a 20 kD cutoff membrane (MPS-1; Amicon, Beverly, MA, USA) was performed to discard chromogens that were linked to albumin-like bilirubinemia and other heavy proteins. In the absence of an international standard for creatinine assay, the linearity of the measurements was verified by using plasma samples from normal subjects in which increasing amounts of desiccated creatinine hydrochloride (MW 149.6; Sigma Chemicals, Perth, Australia) had been added. Linear regression analysis showed that the relationship between measured and expected creatinine concentrations was 1.0008 ± 0.006 (95% confidence interval, 0.997 to 1.020) and that the Y-intercept was 0.014 ± 0.013 (95% confidence interval, -0.013 to 0.041). Squared Spearman rank coefficient of correlation was 0.998. Internal quality controls showed a coefficient of variation of 2.3% during the period.

Assessment of glomerular filtration rate
----------------------------------------

Creatinine clearance was measured according to the formula $CL_{CR} = \frac{UC_{R} \times V}{SC_{R}}$ where urine creatinine (UCR) and serum creatinine (SCR) were expressed in μmol L^-1^and V corresponded to the urinary rate (diuresis) in mL minute^-1^.

At the same time, the GFR was estimated using the Cockcroft Gault formula \[[@B13]\]$CL_{CR} = \frac{(140 - age) \times Weight}{0.8 \times SC_{R}}$ for men, with age in years and weight in Kg. A correcting factor of 0.85 was used for women. The derivate formula proposed by Robert *et al.*\[[@B14]\] uses the ideal body weight and serum creatinine concentration corrected to 85 μmol L^-1^when the actual value is lower than 85 μmol L^-1^. Ideal body weight was determined as 50 kg for men and 45.5 kg for women, plus 2.3 kg for each inch over five feet. The simplified formula of the Modification of Diet in Renal Disease index (sMDRD) \[[@B15]\] was also calculated according to sMDRD = 186.3 × SCR ^-1.154^× age^-0.203^× (1.212 if black) × (0.742 if female) where serum creatinine was expressed in mg dL^-1^.

Statistical analysis
--------------------

Statistical analyses were performed using StatView^®^software version 5.0 (SAS Institute Inc., Cary, NC, USA). Data are presented as mean ± standard deviation (SD) or ratio. Normal distribution of data was tested via Kolmogorov-Smirnov test. Chi-square test or Student\'s *t*-test was performed when appropriate. A logistic regression was performed to discriminate if trauma, age, SAPS II, ideal body weight and sex are independently correlated to the measured CL~CR~. A *P*-value \< 0.05 was considered as statistically significant.

Results
=======

Demographic and renal data are shown in Table [1](#T1){ref-type="table"}. Two hundred, eighty-four patients were consecutively included in this observational study. The process of screening and inclusion in the study is shown in Figure [1](#F1){ref-type="fig"} (flow chart).

###### 

Demographic data

                                                                  NPT^a^(*n*= 140)   PT^b^(*n*= 144)   *P*\*
  --------------------------------------------------------------- ------------------ ----------------- -----------
  Age (yr)                                                        58 ± 17            42 ± 18           \< 0.0001
  Weight (kg)                                                     72 ± 18            75 ± 14           NS
  Height (cm)                                                     170 ± 8            174 ± 9           NS
  Sex (F/M)                                                       52/88              36/108            0.03
  Ideal body weight (Kg)                                          68 ± 11            72 ± 11           0.0006
  SAPS 2                                                          52 ± 14            42 ± 15           \< 0.0001
                                                                                                       
  Total SOFA score                                                3.7 ± 1.5          3.6 ± 1.4         NS
  Respiratory system                                              0.3 ± 0.2          0.5 ± 0.6         
  Coagulation                                                     0.0 ± 0.0          0.0 ± 0.0         
  Liver                                                           0.0 ± 0.0          0.0 ± 0.0         
  Cardiovascular system                                           1.3 ± 0.9          1.4 ± 0.9         
  Neurological system                                             2.5 ± 1.5          2.4 ± 1.5         
  Renal system                                                    0.0 ± 0.0          0.0 ± 0.0         
                                                                                                       
  Mean arterial blood pressure (mmHg)                             83 +/- 10          82 +/- 11         NS
  Systolic arterial blood pressure (mmHg)                         126 +/- 16         125 +/- 17        NS
  Diastolic arterial blood pressure (mmHg)                        63 +/- 10          63 +/- 11         NS
  Heart rate (bpm)                                                91 +/- 17          92 +/- 16         NS
  Serum creatinine (μmol L-1)                                     74 ± 26            72 ± 19           NS
  Measured creatinine clearance (mL minute^-1^1.73 m-2)           85 ± 5             131 ± 5           \< 0.0001
  Diuresis/24H                                                    2,700 ± 1,200      2,500 ± 1,200     NS
  Serum Urea                                                      8.7 ± 5            7 ± 3             NS
  Measured creatinine clearance \< 60 (mL minute^-1^1.73 m-2)     48                 15                0.0003
  Measured creatinine clearance \> 120 (mL minute^-1^.1.73 m-2)   27                 79                \< 0.0001

All data are expressed as ratio or mean ± SD.

\* The *P*-values correspond to comparison between NPT and PT groups.

^a^NPT, non-polytrauma patients.

^b^PT, polytrauma patients.

![**Flow chart showing the process of recruitment**.](cc10013-1){#F1}

The group of 144 PT patients was compared with the group of 140 NPT patients. No difference was found concerning hemodynamic data (Table [1](#T1){ref-type="table"}). No difference was found concerning ventilation pressure. All the patients were ventilated with a tidal volume of 6 to 8 ml/kg, the PEP value was set at 5.8 ± 3 in PT vs 5.5 ± 3 in NPT patients (NS). FiO2 was 45 +/- 16% in PT vs 45 +/- 15 in NPT (NS), with Ph = 7.38 +/- 0.8 vs 7.39 +/- 0.8 (NS), PaO2 = 107 +/- 16 in PT vs 108 +/- 15 in NPT (NS), PaCO2 = 39 +/- 8 in PT vs 40 +/- 9, SaO2 = 97 +/- 3 vs 97 +/- 3 (NS). Glycemia was not different between groups (6.2 +/- 1.7 vs 6.1 +/- 1.8; NS). Twenty-three percent of PT vs 24% of NPT received norepinephrine (NS).

The overall results show that serum creatinine was normal (73 ± 22 μmol L^-1^) and serum urea (8 ± 4 mmol L^-1^) was slightly higher than the normal limits, but with no difference between groups. One hundred, six patients had a CL~CR~above 120 mL minute^-1^1.73 m^-2^, including 79 PT and 27 NPT (*P*\< 0.0001). Only 63 patients had a CL~CR~below 60 mL minute^-1^1.73 m^-2^with 15 PT and 48 NPT (*P*\< 0.0001), whereas nine patients had a CL~CR~below 30 mL minute^-1^1.73 m^-2^, including two PT.

The overall urinary creatinine excretion was 929 ± 678 mg 24 h^-1^1.73 m^-2^for women and 1,369 ± 685 mg 24 h^-1^1.73 m^-2^for men. There was a significant difference between the urinary creatinine excretion of PT and NPT patients (1,489 ± 639 vs 969 ± 688 mg 24 h^-1^1.73 m^-2^respectively, *P*\< 0.001). In the PT group, males had significantly higher urinary creatinine excretion than females (1,630 ± 644 vs 1,067 ± 392 mg 24 h^-1^1.73 m^-2^, *P*\< 0.001).

The overall measured CL~CR~was 108 ± 57 mL minute^-1^1.73 m^-2^. The CL~CR~was higher in PT patients than in NPT patients when using measured CL~CR~(131 ± 56 vs 85 ± 48 mL minute^-1^1.73 m^-2^respectively, *P*\< 0.001).

Most patients with increased CL~CR~(above 120 mL minute^-1^1.73 m^-2^) were PT patients as shown in Table [2](#T2){ref-type="table"}. On the opposite, most patients with decreased CL~CR~(below 60 mL minute^-1^1.73 m^-2^) were NPT patients.

###### 

Comparison of patients with different measured creatinine clearance (CL~CR~)

                                                          Cl~CR~\< 120 (*n*= 178)   Cl~CR~\> 120 (*n*= 106)   *P*\*       Cl~CR~\< 60 (*n*= 63)   Cl~CR~\> 60 (*n*= 221)   *P* ^\#^    *P§*
  ------------------------------------------------------- ------------------------- ------------------------- ----------- ----------------------- ------------------------ ----------- -----------
  Age (yr)                                                56 ± 18                   40 ± 16                   \< 0.0001   63 ± 15                 46 ± 18                  \< 0.0001   \< 0.0001
  Weight (Kg)                                             74 ± 17                   74 ± 14                   NS          73 ± 19                 74 ± 15                  NS          NS
  Sex (F/M)                                               64/114                    24/82                     0.03        35/28                   161/60                   NS          0.0032
  Ideal body weight (Kg)                                  69 ± 12                   72 ± 10                   0.01        65 ± 11                 71 ± 11                  0.0002      \< 0.0001
  SAPS 2                                                  50 ± 15                   43 ± 14                   0.0002      54 ± 14                 45 ± 15                  \< 0.0001   \< 0.0001
  Serum creatinine (μmol L^-1^)                           76 ± 24                   67 ± 19                   0.0001      85 ± 25                 69 ± 20                  \< 0.0001   \< 0.0001
  Diuresis/24H                                            2,400 ± 100               2,800 ± 1200              \< 0.0001   584 ± 224               1,418 ± 694              0.0019      \< 0.0001
  Measured creatinine clearance (mL min^-1^.1.73 m^-2^)   74 ± 30                   166 ± 50                  \< 0.0001   43 ± 11                 127 ± 50                 \< 0.0001   \< 0.0001
  Simplified MDRD (mL minute^-1^1.73 m^-2^)               96 ± 39                   119 ± 45                  \< 0.0001   81 ± 34                 112 ± 43                 \< 0.0001   \< 0.0001
  Cockcroft-Gault (mL minute^-1^1.73 m^-2^)               98 ± 39                   130 ± 34                  0.0005      80 ± 39                 118 ± 36                 \< 0.0001   \< 0.0001
  Robert (mL minute^-1^1.73 m^-2^)                        72 ± 23                   94 ± 23                   \< 0.0001   59 ± 2                  85 ± 2                   \< 0.0001   \< 0.0001
  PT ^b^/NPT ^a^                                          65/113                    79/27                     \< 0.0001   15/48                   129/92                   \< 0.0001   \< 0.0001

All data are expressed as ratio or mean ± SD.

\* The *P*-values correspond to comparison between subgroup with CL~CR~greater than 120 mL minute^-1^1.73 m^-2^versus subgroup with CL~CR~lower than 120 mL minute^-1^1.73 m^-2^.

^\#^The *P*-values correspond to comparaison between subgroup with CL~CR~greater than 60 mL minute^-1^1.73 m^-2^versus subgroup with CL~CR~lower than 60 mL minute^-1^1.73 m^-2^.

§ The *P*-values correspond to comparison between less than 60 mL minute^-1^1.73 m^-2^more than 120 mL minute^-1^1.73 m^-2^.

^a^NPT = non-polytrauma patients.

^b^PT = polytrauma patients.

Patients with CL~CR~greater than 120 mL minute^-1^1.73 m ^-2^were younger (40 ± 16 years vs 56 ± 18 years), had a lower SAPS II score (43 ± 14 vs 50 ± 15) and a higher male ratio as compared with patients presenting a CL~CR~lower than 120 mL minute.

All factors presenting a statistical difference between hyperfiltration and hypofiltration subgroups (Table [2](#T2){ref-type="table"}) were analyzed. Through a logistic regression analysis, including goodness of fit of the model, age and trauma were the only factors independently correlated to CL~CR~(Table [3](#T3){ref-type="table"}).

###### 

Logistic regression for different measured creatinine clearance

                                         *P*\*       Odd ratio (CI 95%)
  -------------------------------------- ----------- ---------------------
  CL~CR~\> 120 mL minute^-1^1.73 m^-2^               
                                                     
  Age                                    \< 0.0001   0.95 (0.93 to 0.97)
  SAPS 2                                 0.56        1.00 (0.98 to 1.04)
  Ideal body weight                      0.29        0.97 (0.93 to 1.02)
  Gender                                 0.564       0.41 (0.12 to 1.4)
  PT                                     0.0001      3.33 (1.8 to 6)
                                                     
  CL~CR~\< 60 mL minute^-1^1.73 m^-2^                
                                                     
  Age                                    \< 0.0001   0.95 (0.93 to 0.97)
  SAPS 2                                 0.36        0.98 (0.95 to 1.02)
  Ideal body weight                      0.3         1.03 (0.97 to 1.09)
  Gender                                 0.8         0.84 (0.97 to 1.09)
  NPT                                    0.02        2.39 (1.15 to 4.97)

PT = polytrauma patients, NPT non polytrauma patients.

\* The *P*-values correspond to logistic regression with CL~CR~greater than 120 mL minute^-1^1.73 m^-2^(C index = 0.56).

^\#^The *P*-values correspond to logistic regression with CL~CR~lower than 60 mL minute^-1^1.73 m^-2^

(C index = 0.58).

Discussion
==========

The present results comparing a population of hemodynamic stable PT patients to a population of hemodynamic stable NPT patients with steady state serum creatinine concentration with a normal creatinine serum value demonstrate that (i) PT patients exhibit dramatic variations of their CrCl; (ii) CrCl is higher in PT patients than in NPT patients; (iii) Age and trauma are independently correlated factors to CL~CR~in our study and in these study conditions.

Considering serum creatinine values, no significant difference was found between PT and NPT groups despite the variations of CrCl. These data demonstrated that a wide range of measured CL~CR~variations exists and, therefore, confirm Hoste data obtained in critically ill patients with serum creatinine within normal range \[[@B16]\]. These authors demonstrated that \"serum creatinine has a low sensitivity for detection of renal dysfunction\". Our results also revealed some opposite trends between CrCl and creatinine measurements, as some patients had significantly lower values of serum creatinine for CL~CR~\> 60 mL minute^-1^1.73 m^-2^than for CL~CR~\< 60 mL minute^-1^1.73 m^-2^. These data underline the inaccuracy of serum creatinine values in estimating the renal function.

Fifty-five percent of PT patients, and only 19% of NPT patients presented a measured CL~CR~above 120 mL minute^-1^1.73 m^-2^. In addition, only 10% of PT patients vs 34% of NPT patients presented a measured CL~CR~below 60 mL minute^-1^1.73 m^-2^. In clinical practice, the diagnosis of increased CL~CR~as a surrogate marker of GFR is important and has largely been demonstrated in burn patients in the setting of antibiotics monitoring: ceftazidime, cefepime, vancomycin and amikacin \[[@B4],[@B5],[@B17],[@B18]\]. In critically ill patients, high CL~CR~required high doses of drugs, which are eliminated by the kidneys to obtain therapeutic concentration. Recently we confirmed the need for CL~CR~monitoring in order to accurately monitor renal function and, therefore, to optimize the doses of antibiotics \[[@B4],[@B19]\].

Our results demonstrate that age, gender, ideal body weight, severity index, trauma patients, and serum creatinine are factors for a CL~CR~above normal (\> 120 mL minute^-1^1.73 m^-2^), and for a moderate renal impairment (CL~CR~\< 60 mL minute^-1^1.73 m^-2^). Through a logistic regression analysis, only two factors (age and trauma patients) remained significantly correlated with a CL~CR~above normal and for a moderate renal impairment. In the current results, 12% of elderly patients (over 65 years) have a CL~CR~greater than 120 mL minute^-1^1.73 m^-2^. The impact of age on CL~CR~is well known and this parameter was, therefore, introduced in the formulas estimating CL~CR~(Cockcroft-Gault, Robert and simplified MDRD) \[[@B13]-[@B15]\]. The decrease in glomerular filtration, the involution of nephronic units and the reduction of the renal blood flow explain the high frequency of renal impairement in elderly patients. However, it should be kept in mind that glomerular ageing is correlated to age in only two-thirds of the patients, and this phenomenon accounts for the inaccuracy of the CL~CR~estimated by calculated formulae \[[@B20]\].

Current evidence suggests that PT (mainly, young patients without significant comorbidities) present with a CL~CR~increase. However, this phenomenon as received little attention in the literature, and dose modification are therefore rarely considered. The present results clearly demonstrate for the first time that trauma is a major factor for CL~CR~increase. Several factors may explain this increase in CL~CR~in PT patients. First, urinary creatinine excretion may be involved in such a phenomenon. A higher creatinine urinary excretion was observed in PT compared with NPT patients whereas serum creatinine was similar in both groups. However, the higher creatinine urinary excretion observed in PT patients was within a normal range. Serum protein variations may impact our results. However, all the patients had a serum protein value between 50 and 55 gL^-1^. It is, therefore, very unlikely that serum protein variations interfere with the present results. Also, regarding hemodynamics, CL~CR~were studied and measured at a steady state in both groups (that is, distant from the admittance). It should be noted that our patients were hemodynamically stable at the time of data collection with no sign of dehydration. Although interference due to some cephalosporin has been described when the creatininemia was measured by using the Jaffe method \[[@B21]\]; no changes in this parameter were observed during the overall period of the study. Sepsis can also reduce creatinine production as described in mice \[[@B22]\]. Moreover, in critically-ill patients, a positive fluid balance may lead to underestimation of the severity of AKI and delay the recognition of a 50% relative increase in sCr \[[@B23]\]. Finally, it should be hypothesized that humoral and inflammatory mechanisms encountered after severe trauma \[[@B24]\] or burn \[[@B1]\] are involved in the observed CL~CR~increase.

The present study encountered some limitations. Increased CL~CR~is related with enhanced renal elimination of circulating drugs. However, describing this phenomenon in terms of current available measures of the GFR at the bedside is still debated. In our study, the GFR was estimated by measured creatinine clearance on a 24-hour urine collection. However, the gold standard for GFR assessment is the measure of inuline clearance \[[@B25]\] but the cost and complexity of this tool limits its application in routine. Another limitation is the lack of consensus regarding the upper limit of normal GFR. However, increasing data support the concept of increased GFR in PT patients, and several reports demonstrated subtherapeutic concentrations of drugs in PT patients \[[@B5],[@B26]\]. Also, a cross-sectional single 24-hr measure of CL~CR~at 10 days in relatively stable patients was performed but fast modifications of kidney function may occur and there is a need for a continuous re-evaluation. Finally, some other factors may influence our results. In particular, fluid status, cardiac output may be significantly altered from baseline. However, whatever the causes of these alterations, the ATLS (Advanced Trauma Life support) principles are applied in our institution regarding resuscitation of PT patients. We, therefore, believe that the current results are broadly representative of the population of PT patients. It could be argued that the external validity of this single-center study may be limited. However, our findings may be relevant to the vast majority of level I trauma centers, provided that ATLS principles are applied in these institutions.

Conclusions
===========

In hemodynamic ICU stable patients with steady state serum creatinine concentration, CL~CR~, which is a surrogate marker of GFR, is higher in polytrauma patients than in other critically ill patients. In ICU patients, the drug monitoring must take into account the glomerular filtration rate. The measure of CL~CR~should be routinely proposed for PT patients in order to adjust dose regimen, especially for drugs with renal elimination (betalactams, ceftazidime, cefepime, piperacillin, vancomycin, aminoglycosides, and so on).

Key messages
============

• In ICU patients with normal serum creatinine, CL~CR~, is higher in trauma than in non-trauma patients.

• The measure of CL~CR~should be proposed in routine for ICU patients in order to adjust dose regimen, especially for drugs with renal elimination.

• Age and trauma were the only factors independently correlated to CL~CR~.

• Glomerular filtration rate should be measured in ICU patient to detect renal filtration abnormalities.

• Serum creatinine is not a good marker for renal function estimation.
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